Your browser doesn't support javascript.
loading
How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments.
Gomez Montero, Melissa; El Alili, Houcine; Hashim, Mahmoud; Wigfield, Peter; Dimova, Mariya; Riley, Ralph; Pascoe, Katie.
Afiliación
  • Gomez Montero M; Ingress-Health, Rotterdam, The Netherlands.
  • El Alili H; Ingress-Health, Rotterdam, The Netherlands.
  • Hashim M; Ingress-Health, Rotterdam, The Netherlands.
  • Wigfield P; Janssen Global Services Inc, 2340, Beerse, Belgium.
  • Dimova M; Ingress-Health, Rotterdam, The Netherlands.
  • Riley R; Janssen Global Services Inc, 92787, Issy-les-Moulineaux, France.
  • Pascoe K; Janssen Global Services Inc, Raritan, NJ, USA.
Pharmacoecon Open ; 6(5): 637-646, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35790681
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacoecon Open Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacoecon Open Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos